ATNF
Price
$0.88
Change
-$0.02 (-2.22%)
Updated
Jul 3 closing price
Capitalization
5.02M
GLMD
Price
$1.82
Change
+$0.02 (+1.10%)
Updated
Jul 3 closing price
Capitalization
4.12M
25 days until earnings call
Interact to see
Advertisement

ATNF vs GLMD

Header iconATNF vs GLMD Comparison
Open Charts ATNF vs GLMDBanner chart's image
180 Life Sciences
Price$0.88
Change-$0.02 (-2.22%)
Volume$33.9K
Capitalization5.02M
Galmed Pharmaceuticals
Price$1.82
Change+$0.02 (+1.10%)
Volume$110.44K
Capitalization4.12M
ATNF vs GLMD Comparison Chart in %
Loading...
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNF vs. GLMD commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNF is a Hold and GLMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ATNF: $0.88 vs. GLMD: $1.83)
Brand notoriety: ATNF and GLMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNF: 27% vs. GLMD: 11%
Market capitalization -- ATNF: $5.02M vs. GLMD: $4.12M
ATNF [@Biotechnology] is valued at $5.02M. GLMD’s [@Biotechnology] market capitalization is $4.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNF’s FA Score shows that 0 FA rating(s) are green whileGLMD’s FA Score has 0 green FA rating(s).

  • ATNF’s FA Score: 0 green, 5 red.
  • GLMD’s FA Score: 0 green, 5 red.
According to our system of comparison, GLMD is a better buy in the long-term than ATNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNF’s TA Score shows that 5 TA indicator(s) are bullish while GLMD’s TA Score has 4 bullish TA indicator(s).

  • ATNF’s TA Score: 5 bullish, 4 bearish.
  • GLMD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATNF is a better buy in the short-term than GLMD.

Price Growth

ATNF (@Biotechnology) experienced а +1.57% price change this week, while GLMD (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ATNF is expected to report earnings on May 15, 2025.

GLMD is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNF($5.02M) has a higher market cap than GLMD($4.12M). ATNF has higher P/E ratio than GLMD: ATNF (0.13) vs GLMD (0.02). GLMD YTD gains are higher at: -42.790 vs. ATNF (-51.615). GLMD has higher annual earnings (EBITDA): -6.07M vs. ATNF (-7.69M). GLMD has more cash in the bank: 15.7M vs. ATNF (3.73M). GLMD has less debt than ATNF: GLMD (41K) vs ATNF (152K). ATNF (0) and GLMD (0) have equivalent revenues.
ATNFGLMDATNF / GLMD
Capitalization5.02M4.12M122%
EBITDA-7.69M-6.07M127%
Gain YTD-51.615-42.790121%
P/E Ratio0.130.02652%
Revenue00-
Total Cash3.73M15.7M24%
Total Debt152K41K371%
FUNDAMENTALS RATINGS
ATNF vs GLMD: Fundamental Ratings
ATNF
GLMD
OUTLOOK RATING
1..100
5035
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
6553
P/E GROWTH RATING
1..100
9797
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLMD's Valuation (36) in the Pharmaceuticals Other industry is in the same range as ATNF (51) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's SMR Rating (97) in the Pharmaceuticals Other industry is in the same range as ATNF (100) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's Price Growth Rating (53) in the Pharmaceuticals Other industry is in the same range as ATNF (65) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

GLMD's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as ATNF (97) in the Financial Conglomerates industry. This means that GLMD’s stock grew similarly to ATNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNFGLMD
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
64%
N/A
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
ATNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHWK1.990.11
+5.85%
Whitehawk Therapeutics Inc
VAPE10.570.07
+0.71%
CEA Industries Inc
LAUR23.640.16
+0.68%
Laureate Education
SEPN11.37-0.03
-0.26%
Septerna Inc
EXAS53.36-0.50
-0.93%
Exact Sciences Corp

ATNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNF has been loosely correlated with PRQR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNF jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNF
1D Price
Change %
ATNF100%
-1.93%
PRQR - ATNF
55%
Loosely correlated
+2.35%
KRRO - ATNF
46%
Loosely correlated
+1.99%
WVE - ATNF
43%
Loosely correlated
+2.96%
JSPR - ATNF
41%
Loosely correlated
-0.73%
BDRX - ATNF
38%
Loosely correlated
-1.29%
More

GLMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLMD has been closely correlated with XBIO. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if GLMD jumps, then XBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLMD
1D Price
Change %
GLMD100%
+0.83%
XBIO - GLMD
88%
Closely correlated
-1.33%
IOBT - GLMD
34%
Loosely correlated
N/A
JSPR - GLMD
31%
Poorly correlated
-0.73%
CDTX - GLMD
28%
Poorly correlated
+1.90%
CRVS - GLMD
28%
Poorly correlated
-0.75%
More